CLASS II ONGOING Device recall · Reported 15 Mar 2023 · FDA Enforcement Report

Patient-Fitted Temporomandibular (TMJ) Reconstruction Prosthesis recalled

Stryker Leibinger GmbH & Co. KG is recalling Patient-Fitted Temporomandibular (TMJ) Reconstruction Prosthesis, distributed in Massachusetts. The recall was initiated on 6 Dec 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesTMJ Reconstruction Prosthesis, Catalog #2208151054, Lot Number W67725 UDI/DI: B004YYMMDDNNNNLM0
Quantity recalled1 unit

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1234-2023
FDA event ID
91479
Recalling firm
Stryker Leibinger GmbH & Co. KG, Freiburg Im Breisgau
Classification
Class II
Status
Ongoing
Recall initiated
6 Dec 2022
FDA classified
7 Mar 2023
Reported
15 Mar 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

6 Dec 2022Recall initiated by company
7 Mar 2023Classified by FDA+91 days
15 Mar 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Device was shipped without having regulatory approval.

Product as listed by the FDA

Patient-Fitted Temporomandibular (TMJ) Reconstruction Prosthesis

Where it was distributed

Distribution of one unit only to a single customer in MA (USA)

Massachusetts

Questions about this recall

Why was it recalled?

Device was shipped without having regulatory approval.

Which lots are affected?

TMJ Reconstruction Prosthesis, Catalog #2208151054, Lot Number W67725 UDI/DI: B004YYMMDDNNNNLM0

Where was it sold?

Distribution of one unit only to a single customer in MA (USA)

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Stryker Leibinger GmbH & Co. KG

All 26

Other Other Medical Devices recalls

All 13,968